Pro Medicus Limited

Equities

PME

AU000000PME8

Advanced Medical Equipment & Technology

Delayed Australian S.E. Other stock markets 12:35:07 2024-05-09 am EDT			5-day change	1st Jan Change
117.3 ^AUD	+0.89%		+4.69%	+22.47%

May. 08	CLSA Upgrades Pro Medicus to Accumulate from Reduce, Price Target is AU$125	MT
Apr. 02	Pro Medicus Limited authorizes a Buyback Plan.	CI

Pro Medicus Limited Announces an Fully Franked Ordinary Dividend for the Period of Twelve Months Ended June 30, 2021, Payable on October 1, 2021

August 17, 2021 at 07:18 pm EDT

Pro Medicus Limited announced an fully franked ordinary dividend of AUD 0.08000000 per share for the period of twelve months ended June 30, 2021. The ex-date is September 9, 2021, record date is September 10, 2021. The payment date is on October 1, 2021.

Latest news about Pro Medicus Limited

CLSA Upgrades Pro Medicus to Accumulate from Reduce, Price Target is AU$125	May. 07	MT
Pro Medicus Limited authorizes a Buyback Plan.	Apr. 01	CI
Pro Medicus Limited announces an Equity Buyback for 10,442,488 shares, representing 10% of its issued share capital.	Apr. 01	CI
Pro Medicus Limited(ASX:PME) added to S&P/ASX 100 Index	Mar. 17	CI
Pro Medicus Limited(ASX:PME) dropped from S&P/ASX Small Ordinaries Index	Mar. 17	CI
Pro Medicus Limited authorizes a Buyback Plan.	Feb. 19	CI
Pro Medicus Limited announces an Equity Buyback for 11,300 shares, representing 0.01% of its issued share capital.	Feb. 19	CI
Transcript : Pro Medicus Limited, H1 2024 Earnings Call, Feb 15, 2024	Feb. 14
Pro Medicus' Net Profit, Revenue Jumps in Fiscal H1	Feb. 14	MT
Pro Medicus Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 14	CI
Pro Medicus' US Arm Launches Computing Platform for Apple	Feb. 07	MT
Pro Medicus' Co-Founders Each Sell One Million Shares	Nov. 21	MT
Pro Medicus Seeks Acquisitions	Nov. 19	CI
Transcript : Pro Medicus Limited - Shareholder/Analyst Call	Nov. 19
Pro Medicus' US Subsidiary Secures AU$20 Million Deal from Oregon Health & Science University	Nov. 13	MT
Australian shares snap three-day losing run to rise on strong commodity stocks	23-10-24	RE
Pro Medicus' US Subsidiary Signs AU$16 Million Contract with South Shore Health	23-10-22	MT
Pro Medicus' Net Profit Jumps 37% in Fiscal Year 2023	23-08-15	MT
Transcript : Pro Medicus Limited, 2023 Earnings Call, Aug 15, 2023	23-08-14
Pro Medicus Limited Announces an Fully Franked Ordinary Dividend for the Period of Twelve Months Ended June 30, 2023, Payable on September 28, 2023	23-08-14	CI
Pro Medicus Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-14	CI
Pro Medicus Signs AU$24 Million Medical Imaging Deal with US Cancer Center	23-07-27	MT
Pro Medicus Starts Share Buyback Program	23-04-02	MT
Pro Medicus Limited announces an Equity Buyback for 10,443,225 shares, representing 10% of its issued share capital.	23-04-02	CI
Pro Medicus Limited authorizes a Buyback Plan.	23-04-02	CI

Chart Pro Medicus Limited

Duration

Period

More charts

Company Profile

Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-12 - Q4 2024 Earnings Release (Projected)

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for Pro Medicus Limited

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

116.3 AUD

Average target price

97.24 AUD

Spread / Average Target

-16.38%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
PRO MEDICUS LIMITED	+22.47%	7.98B
VEEVA SYSTEMS INC.	+4.80%	32.61B
SECTRA AB	+25.15%	3.99B
EVOLENT HEALTH, INC.	-17.44%	3.13B
OMNICELL, INC.	-20.38%	1.38B
LUNIT INC.	-30.40%	1.2B
SIMULATIONS PLUS, INC.	+7.28%	959M
B-SOFT CO.,LTD.	-34.66%	915M
VERADIGM INC.	-27.45%	819M
SURGICAL SCIENCE SWEDEN AB	-18.08%	700M

Medical Software & Technology Services